Literature DB >> 18954632

Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.

Mohammad Hossein Mandegar1, Mohammad Ali Yousefnia, Farideh Roshanali, Hussein Rayatzadeh, Farshid Alaeddini.   

Abstract

OBJECTIVE: In patients with ischemic cardiomyopathy and substantial amounts of dysfunctional but viable myocardium, revascularization cannot always improve the left ventricular ejection fraction. We sought to investigate the interaction between the left ventricular volume and the amount of viable myocardium to predict the left ventricular ejection fraction increase after revascularization.
METHODS: Eighty-five consecutive patients with a depressed left ventricular ejection fraction (mean: 27.3% +/- 5.2%) underwent coronary artery bypass grafting after a dobutamine stress echocardiography had determined that they had at least 4 viable segments. Six months after coronary artery bypass grafting, left ventricular ejection fraction and regional wall motion were reassessed.
RESULTS: Although the left ventricular ejection fraction was expected to recover more than 5% in all 85 patients after coronary artery bypass grafting, it did not improve in 15 patients (17.6%) despite the presence of viable segments. The likelihood of the left ventricular ejection fraction recovery decreased proportionally with an increase in the left ventricular end-systolic volume. The nonimprovers had a higher left ventricular end-systolic volume (164.2 +/- 22.4 mL vs 125.6 +/- 23.4 mL, P = .0001). In addition, the number of viable segments during the dobutamine stress echocardiography had a significant correlation with the ejection fraction increase after 6 months (P < .0001). Patients with 6 viable segments showed a good outcome irrespective of their left ventricular end-systolic volume. In patients with fewer than 6 viable segments, left ventricular end-systolic volume was a major factor in the prognosis: Patients with left ventricular end-systolic volume of 145 or more had a poor left ventricular ejection fraction increase and vice versa.
CONCLUSION: The extent of left ventricular remodeling determines the rate of functional improvement after coronary artery bypass grafting. Patients with a high left ventricular end-systolic volume and fewer than 6 viable segments have a lower likelihood of improvement.

Entities:  

Mesh:

Year:  2008        PMID: 18954632     DOI: 10.1016/j.jtcvs.2007.11.061

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Impact of left ventricular remodelling on outcomes after left ventriculoplasty for ischaemic cardiomyopathy: Japanese surgical ventricular reconstruction group experience.

Authors:  Satoru Wakasa; Yoshiro Matsui; Tadashi Isomura; Shuichiro Takanashi; Atsushi Yamaguchi; Tatsuhiko Komiya; Yasunori Cho; Junjiro Kobayashi; Hitoshi Yaku; Kiyokazu Kokaji; Hirokuni Arai; Yoshiki Sawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-08

Review 2.  Functional mitral regurgitation: a 30-year unresolved surgical journey from valve replacement to complex valve repairs.

Authors:  Francesco Onorati; Francesco Santini; Rajesh Dandale; Andrea Rossi; Esther Campopiano; Konstantinos Pechlivanidis; Daniele Calzaferri; Aldo Milano; Alessandro Mazzucco; Giuseppe Faggian
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

3.  Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.

Authors:  Robert O Bonow; Serenella Castelvecchio; Julio A Panza; Daniel S Berman; Eric J Velazquez; Robert E Michler; Lilin She; Thomas A Holly; Patrice Desvigne-Nickens; Dragana Kosevic; Miroslaw Rajda; Lukasz Chrzanowski; Marek Deja; Kerry L Lee; Harvey White; Jae K Oh; Torsten Doenst; James A Hill; Jean L Rouleau; Lorenzo Menicanti
Journal:  JACC Cardiovasc Imaging       Date:  2015-09-09

4.  Effects of myocardial viability and left ventricular remodeling on survival of patients with heart failure and reduced ejection fraction after coronary artery bypass grafting.

Authors:  Jian Cao; Ran Dong; Kui Zhang; Hongjia Zhang
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

5.  Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction.

Authors:  Sarah McLaughlin; Brian McNeill; James Podrebarac; Katsuhiro Hosoyama; Veronika Sedlakova; Gregory Cron; David Smyth; Richard Seymour; Keshav Goel; Wenbin Liang; Katey J Rayner; Marc Ruel; Erik J Suuronen; Emilio I Alarcon
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.